title: [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.].
abstract: OBJECTIVE
  To investigate the effects of early intensive therapy on beta cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients with different recruiting fasting plasma glucose (FPG) levels.
  
  
  METHODS
  A total of 382 newly diagnosed type 2 diabetic patients with FPG 7.0 - 16.7 mmol/L were randomly assigned to therapy with insulin in the form of continuous subcutaneous insulin infusion (CSII) or multiple daily injection (MDI) or oral hypoglycemic agents (OHA, by using gliclazide and/or metformin) for initial rapid correction of hyperglycemia. The treatments were stopped after euglycemia had been maintained for 2 weeks. The patients were followed longitudinally on diet alone for 1 year. Intravenous glucose tolerances tests (IVGTTs) were performed and blood glucose, insulin and proinsulin were measured before and after therapy as well as at 1-year follow-up. Homeostasis model assessment (HOMA) of beta cell function and insulin resistance index (HOMA-beta and HOMA-IR) were calculated. All the patients were stratified on the recruiting FPG: stratum A (7.0 mmol/L </= FPG < 11.1 mmol/L), stratum B (11.1 mmol/L </= FPG </= 16.7 mmol/L).
  
  
  RESULTS
  More patients in stratum A achieved target glycemic control (94.4% vs 89.8%) and in shorter time [(5.9 +/- 3.8) d vs (6.9 +/- 3.6) d, P < 0.05] as compared with those in stratum B. beta cell function represented by HOMA-beta and acute insulin response (AIR) improved significantly after intensive interventions in both stratum A and B patients. However, the remission rate at 1 year was significantly higher in stratum A patients (47.8%) than those in stratum B (35.7%, P < 0.05). The patients treated with insulin (especially with CSII) had higher remission rates and better improvement of AIR at 1 year follow-up irrespective of the recruiting FPG (CSII or MDI vs OHA: 57.1%, 51.8% vs 32.8% in stratum A, P < 0.05; 44.4%, 38.7% vs 18.6% in stratum B, P < 0.05).
  
  
  CONCLUSIONS
  Compared with OHA, early short time intensive insulin treatment had more favorable outcomes on maintaining AIR and prolonged glycemic remission in newly diagnosed type 2 diabetic patients irrespective of the recruiting FPG levels.
authors.affiliation: Department of Endocrinology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
authors.forename: Yan-Bing
authors.initials: YB
authors.lastname: Li
authors.forename: Long-Yi
authors.initials: LY
authors.lastname: Zeng
authors.forename: Li-Xin
authors.initials: LX
authors.lastname: Shi
authors.forename: Da-Long
authors.initials: DL
authors.lastname: Zhu
authors.forename: Zhi-Guang
authors.initials: ZG
authors.lastname: Zhou
authors.forename: Li
authors.initials: L
authors.lastname: Yan
authors.forename: Hao-Ming
authors.initials: HM
authors.lastname: Tian
authors.forename: Zuo-Jie
authors.initials: ZJ
authors.lastname: Luo
authors.forename: Li-Yong
authors.initials: LY
authors.lastname: Yang
authors.forename: Juan
authors.initials: J
authors.lastname: Liu
authors.forename: Jian-Ping
authors.initials: JP
authors.lastname: Weng
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005215:Fasting; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin